It is an R&D Company, and I invested on that basis. I expect they keep researching and developing !
I actually think their route to quick revenues will be diabetic foot ulcers, but lets see.
They do need some more grunt at director level though and a refinement of strategy
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-11
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.010(1.79%) |
Mkt cap ! $127.5M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.5¢ | 55.0¢ | $124.1K | 222.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 44090 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 1761 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |